Skip Navigation

Matthew S. Davids, MD, MMSc


Medical Oncology

Make an Appointment
Watch Video

Physician

  • Director, Clinical Research, Lymphoma Program
  • Physician
  • Associate Professor of Medicine, Harvard Medical School

Centers/Programs

Clinical Interests

  • Chronic lymphocytic leukemia
  • Lymphoma

Diseases Treated

  • Leukemia, Chronic Lymphocytic (CLL)
  • Lymphoma, Hodgkin
  • Lymphoma, Non-Hodgkin

Contact Information

  • Appointments617-632-6246 (new)
    617-632-5847 (follow-up)
  • Office Phone Number617-632-5847
  • Fax617-582-7890

Bio

After obtaining an A.B. cum laude in chemistry at Harvard College, Dr. Davids completed his M.D. cum laude at Yale University School of Medicine. He served as an intern, resident, and assistant chief resident in internal medicine at New York-Presbyterian Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center in New York City. He then completed his fellowship in hematology and oncology in Dana-Farber/Partners CancerCare, and a Masters in Medical Science (M.M.S.c.) at Harvard Medical School. He is an attending physician in the Division of Lymphoma, where he serves as the Director of Clinical Research, as well as Associate Director of the CLL Center. He is also an Associate Professor of Medicine at Harvard Medical School, and attends on the inpatient hematologic malignancies service at Brigham and Women's Hospital. Dr. Davids has an active translational research program in CLL and non-Hodgkin lymphoma, focusing on studying apoptosis (in particular Bcl-2 biology) in his laboratory, and leading clinical trials to evaluate novel therapeutic strategies in patients with CLL and other hematologic malignancies. Much of his work has focused on the clinical development of new therapeutic regimens in CLL utilizing combinations of targeted inhibitors of Bcl-2, B cell receptor pathway kinases, and other novel agents, as well as utilizing checkpoint blockade to enhance anti-tumor immunity in patients with hematologic malignancies who relapse post allogeneic hematopoietic cell transplantation.

Board Certification:

  • Hematology, 2011
  • Internal Medicine, 2008
  • Medical Oncology, 2011

Fellowship:

  • Dana-Farber/Partners CancerCare, Hematology/Oncology

Residency:

  • New York-Presbyterian Weill Cornell Medical Center and Memorial Sloan-Kettering Cancer Center, Internal Medicine

Medical School:

  • Yale University School of Medicine

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Top